From financialisation to innovation in UK Big Pharma : AstraZeneca and GlaxoSmithKline

From financialisation to innovation in UK Big Pharma AstraZeneca and GlaxoSmithKline

The tension between innovation and financialisation is central to the business corporation. Innovation entails a 'retain-and-reinvest' allocation regime that can form a foundation for stable and equitable economic growth. Driven by shareholder-value ideology, financialisation entails a sh...

Descripción completa

Detalles Bibliográficos
Otros Autores: Tulum, Öner, author (author), Andreoni, Antonio, author, Lazonick, William, author
Formato: Libro electrónico
Idioma:Inglés
Publicado: Cambridge : Cambridge University Press 2022.
Edición:First edition
Colección:Cambridge elements. Elements in reinventing capitalism
Materias:
AstraZeneca (Firm) > Finance.
GlaxoSmithKline > Finance.
Pharmaceutical industry > Great Britain > Finance.
Biotechnology industries > Great Britain > Finance.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009769418006719

Ejemplares similares

Ejemplares similares